Cargando…
The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years
SUMMARY: The Forteo Patient Registry (FPR) aims to estimate the incidence of osteosarcoma in US patients treated with teriparatide. Enrollment began in 2009 and will continue through 2019, with linkage planned through 2024. To date, no incident cases of osteosarcoma have been identified among patien...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154045/ https://www.ncbi.nlm.nih.gov/pubmed/29978254 http://dx.doi.org/10.1007/s00198-018-4604-8 |